|
|
This is only a preview of the paper
Click here to register and get the full text.
Existing members click here to login
|
|
|
SARS The Centers for Disease Control and Prevention (CDC) is investigating a new disease called severe acute respiratory syndrome (SARS) that has recently been reported in Asia, North America, and Europe. Virus hunters from the World Health Organization have began tracking the murky history of SARS through squalid farms and public markets near Foshan, China, where the outbreak began last November. So what is SARS? SARS is a respiratory illness that usually begins with a fever greater than 100.4 F (>38.0 C). The fever is sometimes associated with chills or other symptoms, including headache, general feeling of discomfort and body aches. Some people also experience a dry cough and trouble breathing. The incubation period for SARS is typically 2 to 7 days; however, isolated reports suggested an incubation period as long as 10 days. The CDC currently recommends that patients who suspect SARS receive the same treatment that would be used for any patients with serious community-acquired atypical pneumonia of unknown cause. At present, the most effective treatment regimen, if any, is unknown. In several locations, therapy has included antivirals such as oseltamivir or ribavirin. The efficiency of these treatments remains unknown. One of the most terrifying issues to date regarding SRAS is the rate at which it has spread. If the virus moves faster that our scientific communications and control capacities, then we could be in for a long, difficult race. The primary way that SARS appears to spread is by close person-to-person contact.
Approximate Word count = 976
Approximate Pages = 3.9
(250 words per page double spaced)
|
|
|
|
|
|